Man Group PLC Sorrento Therapeutics, Inc. Transaction History

Man Group PLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.24 - $2.33 $225,680 - $424,060	-182,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.0 - $4.9 $364,000 - $891,800	182,000 New	182,000 $424,000
Q2 2021 Aug 16, 2021	SELL	$6.35 - $10.0 $1.01 Million - $1.6 Million	-159,775 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$7.03 - $16.51 $1.12 Million - $2.64 Million	159,775 New	159,775 $1.32 Million
Q4 2018 Feb 14, 2019	SELL	$2.01 - $4.24 $510,519 - $1.08 Million	-253,990 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$4.22 - $7.5 $1.07 Million - $1.9 Million	253,990 New	253,990 $1.12 Million
Q2 2018 Aug 14, 2018	SELL	$4.75 - $8.0 $6.38 Million - $10.7 Million	-1,342,616 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$4.5 - $9.95 $6.04 Million - $13.4 Million	1,342,616 New	1,342,616 $6.91 Million

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.